Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Peadiatric And Adult Study Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04801420

Recruitment Status : Active, not recruiting

First Posted : March 17, 2021

Last Update Posted : July 27, 2021

Sponsor:

Collaborator:

Pfizer

Information provided by (Responsible Party):

Valneva Austria GmbH

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	February 2023
Estimated Study Completion Date :	January 2026

To Top